Figure 4.

(A,B). Graphs of the distribution of causative agents by medication class and by medication (A): Others: tyrosine kinase inhibitors, immunomodulatory, non-steroidal anti-inflammatory drugs (NSAIDs), diuretic, antirheumatic, proton-pump inhibitors, antithyroid, antitubercular, oxazolidinones, titanium bioprosthesis, analgesics, monoalkylamines, antipsychotics, alkylating agents, acid oxidation inhibitors, 3-hidroxi-3-methyl-glutaril-CoA reductase inhibitors, anticoagulant, indanones, and dpp-4 inhibitors. (B): Others: amoxicillin, nitrofurantoin, trimethoprim-sulfamethoxazole, ciprofloxacin, vemurafenib, phenytoin, strontium ranelate, sitagliptin, diaphenylsulfone, clopidogrel, ethambutol, quetiapine, febuxostat, sorafenib, fluindione, titanium bioprosthesis, furosemide, omeprazole, ibuprofen, propylthiouracil, lamotrigine, rosuvastatin, leflunomide, sodium valproate, lenalidomide, spironolactone, chlorambucil, sulphasalazine, cefepime, trimetazidine, minocycline, cyanamide, clindamycin, zonisamide, acetaminophen, linezolid, and meropenem.